SCD and metabolic dysfunction-associated steatotic liver disease: Deletion of Asah2 alleviates diet-induced nonalcoholic steatohepatitis/nonalcoholic fatty liver disease via downregulation of stearoyl-CoA desaturase (Scd1) and reduces cholesterol accumulation (75).